Blog

November 28, 2014April 24, 2018

Partnership between Carl Zeiss and FYidoctors

Carl Zeiss Vision Canada and FYidoctors announce a partnership to produce ZEISS lenses.

Carl Zeiss Vision Canada authorized FYidoctors as the first non‐ZEISS lab to produce ZEISS lenses in Canada because of their commitment to outstanding customer service and their growing network of optometrists. The Eyence Lab will supply the FYidoctors network which includes over 280 locations and over 450 optometrists between its corporately owned and Vision Source Canada offices.

In addition to the ZEISS branded products, ZEISS has developed private label lens designs for the FYidoctors network and Vision Source Canada offices.

“FYidoctors and ZEISS share the goal of providing the best possible visual experience to their patients throughout Canada,” said John Dillon (President of Carl Zeiss Vision Canada). “We are proud to have them as a partner and distributor of our lenses.”

For further information: https://www.optiknow.ca/wp-content/uploads/2014/11/FYidoctors-NEWS-RELEASE1.pdf

November 27, 2014April 24, 2018

COS launches the website Fitson & You

Two years after launching its house brand Fitson & You, Canadian Optical Supply Company Ltd (COS) has launched the website of its brand Fitson & You. Made in South Korea, Fitson & You frames are mostly designed in ultem, an ultra-light and flexible shape-memory material. Fitson & You eyewear styles are classic with a modern twist, perfect for capturing the individuality of each person who wears them.

For more information: http://www.fitsonandyou.com/

November 27, 2014April 24, 2018

J.F. REY launches Trompe-l’œil collection

In its Trompe-l’œil collection, J.F. REY uses a folding technique that will delight origami fans. A single sheet of two-colour stainless steel becomes a frame of astonishing volume, due to an energetic backwards and forwards fold. http://www.jfrey.fr/

November 26, 2014April 24, 2018

New postoperative implant is effective

The first ever tear duct implant developed to treat inflammation and pain following cataract surgery could be a good alternative to eye drops.

The device automatically delivers the correct level of postoperative medication in patients. After 30 days, it liquefies and is evacuated through the tear ducts, without the need for outside intervention.

Tested in four American ophthalmology practices, the device delivered dexamethasone into the eyes of 30 patients over 30 days, while 30 other patients received a placebo. On day one, the placebo group reported pain three times higher than the medicated group. After 14 days, the pain was 11 times higher than it was for the others.

For further information: http://www.newswise.com/articles/tear-duct-implant-effective-at-reducing-pain-and-inflammation-in-cataract-surgery-patients

November 26, 2014April 24, 2018

Mitsui to relaunch the emPower electronic glasses

A year after PixelOptics filed for bankruptcy, a Mitsui Chemical subsidiary is getting ready to relaunch what was once its lead product: the emPower electronic glasses.

Developed by PixelOptics and Panasonic Healthcare, the patented technology for the glasses allows the wearer to adjust the focus, thanks to liquid crystals. The technology was acquired at an auction held by Mitsui Chemical, a Japanese supplier of the high-index resin used to make the lenses.

Whole You, a new Mitsui subsidiary based in California, will try to re-launch an enhanced version of the emPower glasses. The company hopes to sell the eyewear through eyecare professionals.

For further information: http://www.whole-you.com/news-events/news